NPHP4 p.Ala940Val
c.2819C>T · rs200136271 · VCV596431
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1229 | likely benign |
|---|---|---|
| REVEL | 0.187 | benign-leaning |
| SaProt | LLR -7.22 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.7 | GERP -2.8, phastCons 1 |
| Regional constraint | o/e 1.02 | unconstrained · MANE · 123 kb · p 0.49 · regional, not allelic |
| Overall | ||
| CADD | 13.62 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.0735% | 1,361 |
| Middle Eastern | 0.0168% | 5,968 |
| South Asian | 0.00445% | 22,483 |
| Admixed American | 0.00169% | 59,022 |
| Remaining individualsnot grpmax-eligible | 0.00161% | 62,150 |
| European (non-Finnish) | 0.00051% | 195,929 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NPHP4
- Protein
- p.Ala940Val
- Coding
- c.2819C>T
- MANE Select
- NM_015102
- dbSNP
- rs200136271
- Type
- single nucleotide variant
- Location
- chr1:5875099 (GRCh38)
- Gene constraint
- LOEUF 1.183 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 72.44
- Residue 940
- the 'sufficient for basal bodies localization' region; a UniProt-annotated variant site (sequence variant)
Disease context
nephronophthisis 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Senior-Loken syndrome 4nephronophthisis
For Nephronophthisis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 100 000 (Finland)
Similar variants
- NPHP4 p.Ala940= Conflicting classifications of pathogenicity ★ same residue
- NPHP4 p.Ala940Glu Uncertain significance ★ ⚠ same residue
- NPHP4 c.2304+1G>A Pathogenic ★★ same condition
- NPHP4 c.2611+1G>A Pathogenic/Likely pathogenic ★★ same condition
- NPHP4 c.2611+1G>C Pathogenic ★★ same condition
- NPHP4 c.3644+1G>A Pathogenic/Likely pathogenic ★★ same condition
- NPHP4 c.3644+1G>T Pathogenic/Likely pathogenic ★★ same condition
- NPHP4 c.517+1G>A Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nphp4-p-ala940val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown